Ironwood Pharmaceuticals Provides First Quarter 2018 Investor Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- US futures fall on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Ironwood Pharma (IRWD) to Resume Trading at 8:30 am ET
May 1, 2018 8:20 AM EDTIronwood Pharma (NASDAQ: IRWD) to Resume Trading at 8:30 am ET
... MoreIronwood Pharma (IRWD) to Separate Soluble Guanylate Cyclase Business from Commercial and Gastrointestinal Business
May 1, 2018 8:00 AM EDTIronwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a commercial biotech company, today announced that its Board of Directors has authorized an intent to separate into two independent, publicly traded companies (Ironwood and R&D Co.). The separation is expected to be completed in the first half of 2019 and is anticipated to be tax-free to Ironwood shareholders.
... More
Ironwood Pharma (IRWD) Misses Q1 EPS by 4c
May 1, 2018 7:56 AM EDTIronwood Pharma (NASDAQ: IRWD) reported Q1 EPS of ($0.27), $0.04 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $69.16 million versus the consensus estimate of $78.87 million.
For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.
... More